DURECT Corporation Announces Exercise of Over-allotment Option in Initial Public Offering
CUPERTINO, Calif., Nov. 2 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced that the underwriters of its recent initial public offering of common stock have exercised their over-allotment option in part and purchased an additional 700,000 shares at the initial public offering price of $12.00 per share. All of the over-allotment shares were sold by […]